Stocks360

Hempstract, Inc. (HPST)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

Share: Facebook X WhatsApp SMS
$0.03

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$25.55M
PE (TTM)
-33.33
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
1.79
Day Range
$0.03 – $0.04
52-wk Range
$0.00 – $0.04
Avg Volume
N/A
Volume
16.60K

Hempstract, Inc. (HPST) is a publicly traded company in the Healthcare sector. Latest price: $0.03. Market cap $25.55M. Trailing PE -33.33. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Hempstract, Inc.

Operating across the United States, Hempstract, Inc. develops and supplies products centered around cannabidiol (CBD) and cannabigerol (CBG). Its catalog features CBD in isolate powder form, alongside various distillate oils. The enterprise adopted the Hempstract, Inc. moniker in November 2020, having previously been known as Riverdale Oil and Gas Corporation. This firm maintains its principal office in Warden, Washington.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-33.33×
P/S (TTM)0.00×
P/B-25.37×
PEG0.07×
P/FCF (TTM)-41.56×
EV / EBITDA-47.03×
EV / Sales0.00×
Earnings Yield-3.05%
Free Cash Flow Yield-2.41%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$26.61M
Net Income (TTM)-$779.50K
Free Cash Flow (TTM)-$702.17K
Net Debt$1.06M
Working Capital-$1.35M
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Return on Equity125.29%
Return on Invested Capital-110.12%

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap